Yafen Yu

691 total citations
29 papers, 321 citations indexed

About

Yafen Yu is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Yafen Yu has authored 29 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Yafen Yu's work include Psoriasis: Treatment and Pathogenesis (6 papers), Connective tissue disorders research (3 papers) and Dermatology and Skin Diseases (3 papers). Yafen Yu is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (6 papers), Connective tissue disorders research (3 papers) and Dermatology and Skin Diseases (3 papers). Yafen Yu collaborates with scholars based in China, United States and France. Yafen Yu's co-authors include Xingwang Wu, Jin Gu, Xiaoying Zhao, Yaqing Du, Jumin Zhou, Guijun Chen, Nigel W. Fraser, Dong‐Dong Wu, Benxia Hu and Xin Li and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Advanced Science.

In The Last Decade

Yafen Yu

28 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yafen Yu China 10 112 62 48 41 40 29 321
Lisa Abernathy‐Close United States 12 122 1.1× 203 3.3× 71 1.5× 64 1.6× 37 0.9× 24 498
Caroline Hodin Netherlands 9 244 2.2× 87 1.4× 66 1.4× 30 0.7× 36 0.9× 19 526
Alexandra Martin United States 11 75 0.7× 68 1.1× 72 1.5× 56 1.4× 59 1.5× 28 363
Yong Joon Kim South Korea 14 155 1.4× 27 0.4× 17 0.4× 69 1.7× 42 1.1× 73 601
Yonghong Guo China 13 140 1.3× 84 1.4× 91 1.9× 146 3.6× 22 0.6× 44 506
Gaganpreet Kaur United States 12 172 1.5× 62 1.0× 41 0.9× 28 0.7× 33 0.8× 24 563
Rosa Lavieri Italy 8 152 1.4× 115 1.9× 40 0.8× 22 0.5× 10 0.3× 9 323
Trine B. Levring Denmark 8 125 1.1× 202 3.3× 77 1.6× 54 1.3× 60 1.5× 11 621
Amal F. Alshammary Saudi Arabia 10 103 0.9× 29 0.5× 45 0.9× 33 0.8× 31 0.8× 36 281

Countries citing papers authored by Yafen Yu

Since Specialization
Citations

This map shows the geographic impact of Yafen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yafen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yafen Yu more than expected).

Fields of papers citing papers by Yafen Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yafen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yafen Yu. The network helps show where Yafen Yu may publish in the future.

Co-authorship network of co-authors of Yafen Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yafen Yu. A scholar is included among the top collaborators of Yafen Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yafen Yu. Yafen Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Yafen, Bao Li, Zhuo Li, et al.. (2024). Cutaneous Calcium/Calmodulin‐Dependent Protein Kinase II‐γ–Positive Sympathetic Nerves Secreting Norepinephrine Dictate Psoriasis. Advanced Science. 11(23). e2306772–e2306772. 7 indexed citations
2.
Yu, Yafen, Tianyu Zheng, Yuan Qin, et al.. (2024). Establishment of a high-sensitivity time-resolved fluorescence immunoassay with PLA2R-IgG1 antibody and its clinical application in idiopathic membranous nephropathy prognosis. Clinica Chimica Acta. 565. 120019–120019. 1 indexed citations
4.
Yu, Yafen, Qi Zhen, Yanqin Yu, et al.. (2023). Genome‐wide meta‐analyses identify five new risk loci for nonsyndromic orofacial clefts in the Chinese Han population. Molecular Genetics & Genomic Medicine. 11(10). e2226–e2226. 2 indexed citations
5.
Li, Jun, et al.. (2023). Immune-related ureteritis and cystitis induced by immune checkpoint inhibitors: Case report and literature review. Frontiers in Immunology. 13. 1051577–1051577. 12 indexed citations
6.
Mao, Yiwen, Huiyao Ge, Weiwei Chen, et al.. (2023). RasGRP1 influences imiquimod-induced psoriatic inflammation via T-cell activation in mice. International Immunopharmacology. 122. 110590–110590. 4 indexed citations
7.
Zhang, Yi, Yafen Yu, Yufei Xu, et al.. (2022). Novel RARS2 Variants: Updating the Diagnosis and Pathogenesis of Pontocerebellar Hypoplasia Type 6. Pediatric Neurology. 131. 30–41. 2 indexed citations
8.
Chen, Shirui, Xia Hu, Qiongqiong Xu, et al.. (2022). Rare mutations in NLRP3 and NLRP12 associated with familial cold autoinflammatory syndrome: two Chinese pedigrees. Clinical Rheumatology. 41(11). 3461–3470. 7 indexed citations
9.
Xu, Qiongqiong, Xiaodong Zheng, Yiwen Mao, et al.. (2022). Gene interaction analysis of psoriasis in Chinese Han population. Molecular Genetics & Genomic Medicine. 10(5). e1858–e1858. 1 indexed citations
10.
Zhang, Ruixue, Lu Cao, Weiwei Chen, et al.. (2021). Fine-Mapping of the Major Histocompatibility Complex Region Linked to Leprosy in Northern China. Frontiers in Genetics. 12. 768259–768259.
11.
Cao, Lu, Yong Liang, Shirui Chen, et al.. (2021). Novel missense mutation of SASH1 in a Chinese family with dyschromatosis universalis hereditaria. BMC Medical Genomics. 14(1). 168–168. 9 indexed citations
12.
Li, Xin, Yafen Yu, Fengchao Lang, et al.. (2021). Cohesin promotes HSV-1 lytic transcription by facilitating the binding of RNA Pol II on viral genes. Virology Journal. 18(1). 26–26. 9 indexed citations
13.
Ge, Huiyao, Bao Li, Qiongqiong Xu, et al.. (2019). Differential occurrence of lysine 2-hydroxyisobutyrylation in psoriasis skin lesions. Journal of Proteomics. 205. 103420–103420. 20 indexed citations
14.
Yu, Yafen, et al.. (2017). Mechanisms of oxidative stress effects of the NADPH oxidase-ROS-NF-κB transduction pathway and VPO1 on patients with chronic obstructive pulmonary disease combined with pulmonary hypertension.. European review for medical and pharmacological sciences. 21(15). 3459–3464. 17 indexed citations
15.
Hu, Benxia, Xin Li, Yongxia Huo, et al.. (2016). Cellular responses to HSV-1 infection are linked to specific types of alterations in the host transcriptome. Scientific Reports. 6(1). 28075–28075. 52 indexed citations
16.
Yu, Yafen, et al.. (2015). [Relationship of genotypes with clinical phenotypes and outcomes in children with cobalamin C type combined methylmalonic aciduria and homocystinuria].. PubMed. 17(8). 769–74. 9 indexed citations
17.
Yu, Yafen, Man Hu, Fang Li, et al.. (2012). Identification of a mutation in the WISP3 gene in three unrelated families with progressive pseudorheumatoid dysplasia. Molecular Medicine Reports. 12(1). 419–425. 15 indexed citations
18.
Jiang, Shanqun, Yafen Yu, Scott A. Venners, et al.. (2010). Effects of MTHFR and MS gene polymorphisms on baseline blood pressure and Benazepril effectiveness in Chinese hypertensive patients. Journal of Human Hypertension. 25(3). 172–177. 5 indexed citations
19.
Jiang, Shanqun, Guangyun Mao, Xiumei Hong, et al.. (2008). Renin-Angiotensin-Aldosterone System (RAAS) gene polymorphisms andantihypertensive response to irbesartan in Chinese hypertensives. Methods and Findings in Experimental and Clinical Pharmacology. 30(4). 307–307. 5 indexed citations
20.
Jiang, Shanqun, Guangyun Mao, S. Zhang, et al.. (2006). CYP2C9 lle359Leu polymorphism, plasma irbesartan concentration andacute blood pressure reductions in response to irbesartan treatmentin Chinese hypertensives. Methods and Findings in Experimental and Clinical Pharmacology. 28(1). 19–19. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026